Aldebaran Financial’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,791
Closed -$304K 78
2022
Q2
$304K Buy
8,791
+1,025
+13% +$43.5K 0.32% 64
2022
Q1
$560K Buy
7,766
+3,140
+68% +$226K 0.44% 53
2021
Q4
$425K Sell
4,626
-898
-16% -$107K 0.31% 60
2021
Q3
$700K Buy
5,524
+170
+3% +$24.8K 0.57% 45
2021
Q2
$880K Sell
5,354
-111
-2% -$18K 0.72% 42
2021
Q1
$993K Sell
5,465
-20
-0.4% -$4.64K 0.88% 38
2020
Q4
$1.1M Buy
5,485
+945
+21% +$192K 1.02% 33
2020
Q3
$995K Buy
+4,540
New +$961K 1.03% 33

Other funds holding TDOC

Aldebaran Financial's TDOC Position: Q3 2022 in Review

Aldebaran Financial sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 8,791 shares — an estimated $304K sold.

Aldebaran Financial first reported a position in TDOC in Q3 2020 and held it in 8 quarters. The position peaked at $1.1M in Q4 2020. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Aldebaran Financial reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Aldebaran Financial sold 8,791 Teladoc Health shares in Q3 2022, an estimated $304K.
  • Aldebaran Financial first reported a position in Teladoc Health in Q3 2020 and held it in 8 quarters.
  • Aldebaran Financial's Teladoc Health position peaked at $1.1M in Q4 2020.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Aldebaran Financial's 13F filing for Q3 2022, filed 14 Nov 2022.